ResMed (RMD)
(Delayed Data from NYSE)
$186.53 USD
+2.69 (1.46%)
Updated Jun 26, 2024 04:00 PM ET
After-Market: $186.50 -0.03 (-0.02%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth A Momentum A VGM
Brokerage Reports
ResMed Inc. [RMD]
Reports for Purchase
Showing records 121 - 140 ( 528 total )
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Optimized Entry and Exit Levels for RMD 81122
Provider: Stock Traders Daily
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Optimized Entry and Exit Levels for RMD 8122
Provider: Stock Traders Daily
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Now We''re Talking a Potential PHG Consent Decree
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
MedTech 2H22 Outlook - Whack-a-Mole Environment; Think We Need a Bigger Hammer
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Optimized Entry and Exit Levels for RMD 72122
Provider: Stock Traders Daily
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Company: ResMed Inc.
Industry: Medical - Products
Optimized Entry and Exit Levels for RMD 71122
Provider: Stock Traders Daily
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Optimized Entry and Exit Levels for RMD 7122
Provider: Stock Traders Daily
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: ResMed Inc.
Industry: Medical - Products
Optimized Entry and Exit Levels for RMD 62122
Provider: Stock Traders Daily
Analyst: Research Department